Skip to main content
Fig. 8 | BMC Cancer

Fig. 8

From: Cellular senescence and metabolic reprogramming model based on bulk/single-cell RNA sequencing reveals PTGER4 as a therapeutic target for ccRCC

Fig. 8

PTGER4 inhibited RCC progression in vivo. (A) The growth rate and weight of subcutaneous tumors after PTGER4 overexpression are shown. (B) The apoptosis of subcutaneous tumor cells in the PTGER4 overexpression group and control group is shown. (C) The proliferation of subcutaneous tumor cells in the PTGER4 overexpression group and control group is shown. (D) Neutral fatty acid levels in subcutaneous tumors of the PTGER4 overexpression group and control group are shown. (E) The expression of cell cycle-related proteins and cell senescence-related proteins in subcutaneous tumors of the PTGER4 overexpression group and control group is shown

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us